RP-TLC Determination of the Lipophilicity of 1-Substituted Pyrrolidin-2-one Derivatives. Correlation of Lipophilicity with Affinity for α-Adrenoceptors
被引:9
作者:
Kulig, Katarzyna
论文数: 0引用数: 0
h-index: 0
机构:
Jagiellonian Univ, Coll Med, Fac Pharm, Dept Physicochem Drug Anal, PL-30688 Krakow, PolandJagiellonian Univ, Coll Med, Fac Pharm, Dept Physicochem Drug Anal, PL-30688 Krakow, Poland
Kulig, Katarzyna
[1
]
Malawska, Barbara
论文数: 0引用数: 0
h-index: 0
机构:
Jagiellonian Univ, Coll Med, Fac Pharm, Dept Physicochem Drug Anal, PL-30688 Krakow, PolandJagiellonian Univ, Coll Med, Fac Pharm, Dept Physicochem Drug Anal, PL-30688 Krakow, Poland
Malawska, Barbara
[1
]
机构:
[1] Jagiellonian Univ, Coll Med, Fac Pharm, Dept Physicochem Drug Anal, PL-30688 Krakow, Poland
RP-TLC;
Pyrrolidin-2-one derivatives;
Lipophilicity;
R(M)(0);
Affinity for alpha-adrenoceptors;
THIN-LAYER CHROMATOGRAPHY;
DRUG PROPERTIES;
D O I:
10.1556/JPC.22.2009.2.12
中图分类号:
O65 [分析化学];
学科分类号:
070302 ;
081704 ;
摘要:
The relative lipophilicity (R(M)(0)) of fourteen 1-substituted pyrrolidin-2-one derivatives has been measured by use of RP-TLC plates and mixtures of acetonitrile and pH 7.0 Tris buffer with volume fractions of acetonitrile between 20 and 80% were used as mobile phases. Retention data (R(M)) obtained by this method were exponentially dependent on acetonitrile concentration and enabled estimation of the relative lipophilicity corresponding to pH 7.0 Tris buffer as mobile phase. 1-{2-Hydroxy-3-[4-(3-methoxyphenyl)piperazin-1-yl]propyl}pyrrolidin-2-one had the highest relative lipophilicity (1.33) and butylcarbamic acid 1-[4-(2-methoxyphenyl)piperazin-1-ylmethyl]-2-(2-oxopyrrolidin-1-yl)ethyl ester had the lowest (0.72). Comparison of R(M)(0) values obtained with the affinity of the compounds tested for alpha-adrenoceptors enable formulation of preliminary equations for quantitative structure-activity relationships (QSAR).
机构:
Charles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech RepublicCharles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech Republic
Kresta, J
Kastner, P
论文数: 0引用数: 0
h-index: 0
机构:
Charles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech RepublicCharles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech Republic
Kastner, P
Klimes, J
论文数: 0引用数: 0
h-index: 0
机构:
Charles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech RepublicCharles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech Republic
Klimes, J
Klimesová, W
论文数: 0引用数: 0
h-index: 0
机构:
Charles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech RepublicCharles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech Republic
机构:
Pfizer Global Res & Dev, Groton Labs, Exploratory Med Sci, Groton, CT 06340 USAPfizer Global Res & Dev, Groton Labs, Exploratory Med Sci, Groton, CT 06340 USA
机构:
Charles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech RepublicCharles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech Republic
Kresta, J
Kastner, P
论文数: 0引用数: 0
h-index: 0
机构:
Charles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech RepublicCharles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech Republic
Kastner, P
Klimes, J
论文数: 0引用数: 0
h-index: 0
机构:
Charles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech RepublicCharles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech Republic
Klimes, J
Klimesová, W
论文数: 0引用数: 0
h-index: 0
机构:
Charles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech RepublicCharles Univ Prague, Fac Pharm Hradec Kralove, CZ-50005 Hradec Kralove, Czech Republic
机构:
Pfizer Global Res & Dev, Groton Labs, Exploratory Med Sci, Groton, CT 06340 USAPfizer Global Res & Dev, Groton Labs, Exploratory Med Sci, Groton, CT 06340 USA